🇺🇸 FDA

Company profile · Sponsor

Vistagen

Vistagen Therapeutics

VTGN · NYSE pharma SOUTH SAN FRANCISCO, CA, USA
Pipeline
10
Drugs
0
Patents
6

Quick answer

Vistagen (VTGN) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 6 patents to this profile..

Company facts

Ticker VTGN
Exchange NYSE
Company type pharma
Headquarters SOUTH SAN FRANCISCO, CA, USA
SEC CIK 0001411685

Pipeline (10)

Search pipeline →

  1. Fasedienol Nasal Spray

    Vistagen

    Social Anxiety Disorder

    phase 3 small molecule active

    1 trial

  2. Fasedienol Nasal Spray

    Vistagen

    Social Anxiety Disorder (SAD)

    phase 3 small molecule active

    1 trial

  3. PH94B

    Vistagen

    Social Anxiety Disorder

    phase 3 small molecule terminated

    1 trial

  4. PH94B Nasal Spray

    Vistagen

    Social Anxiety Disorder

    phase 3 small molecule terminated

    2 trials

  5. AV-101

    Vistagen

    Parkinson Disease

    phase 2 small molecule active

    1 trial

  6. AV-101

    Vistagen

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial

  7. Fasedienol Nasal Spray - Placebo Nasal Spray

    Vistagen

    Social Anxiety Disorder

    phase 2 small molecule active

    1 trial

  8. PH94B

    Vistagen

    Adjustment Disorder With Anxious Mood

    phase 2 small molecule completed

    1 trial

  9. Placebo

    Vistagen

    Healthy

    phase 2 small molecule completed

    1 trial

  10. AV-101

    Vistagen

    Drug Drug Interaction

    phase 1 small molecule active

    1 trial

Patents (6)

Search patents →

  1. US 12036198

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10980758

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10632091

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10617663

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9993453

    Dosage forms and therapeutic uses L-4-chlorokynurenine

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9993450

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Vistagen?

Vistagen (VTGN) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 6 patents to this profile..

What pipeline programs does Vistagen sponsor?

We track 10 ClinicalTrials.gov-linked programs for Vistagen, including Fasedienol Nasal Spray and 9 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Vistagen company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.